ArborMetrix Appoints Brookings Quality Healthcare Expert Mark McClellan to Board of Directors
Former CMS Administrator and FDA Commissioner to provide strategic insights as company grows to meet national demand for innovative healthcare analytics
ANN ARBOR, Mich., March 5, 2014 /PRNewswire/ -- ArborMetrix, Inc., a leading provider of real-time healthcare analytics, announced today that Mark McClellan, M.D., Ph.D, M.P.A., a senior fellow and director of the Health Care Innovation and Value Initiative at the Brookings Institution, is joining its Board of Directors.
A physician and economist, Dr. McClellan is the former administrator of the Centers for Medicare & Medicaid Services (CMS) and also the former commissioner of the U.S. Food and Drug Administration. In those roles, he led initiatives such as the Medicare prescription drug benefit and the FDA's Critical Path Initiative, as well as public-private initiatives to develop better information on the quality and cost of care.
"ArborMetrix represents the future of improving health care quality through the best possible insights from increasingly complex data," said Dr. McClellan. "Their clinical analytics and performance improvement tools are enabling clinicians and health care systems to improve patient outcomes while reducing costs."
Dr. McClellan is a member of the Institute of Medicine, where he chairs the IOM Roundtable on Value and Science-Driven Health Care. He also serves on the board of the Reagan-Udall Foundation for the FDA and is a research associate at the National Bureau of Economic Research. He recently served as co-chair of the Robert Wood Johnson Foundation Commission to Build a Healthier America.
"We are excited to welcome Dr. Mark McClellan to the ArborMetrix Board of Directors," said Brett Furst, CEO of ArborMetrix. "Mark has an exemplary record throughout his career of driving both public and private industry initiatives aimed at improving the quality of healthcare. His insights will help drive ArborMetrix's growth strategy as we continue to provide the most innovative performance measurement and clinical intelligence solutions available in acute and specialty care today."
Dr. McClellan holds an M.D. from the Harvard University–Massachusetts Institute of Technology (MIT) Division of Health Sciences and Technology, a Ph.D. in economics from MIT, an M.P.A. from Harvard University, and a B.A. from the University of Texas at Austin. He completed his residency training in internal medicine at Boston's Brigham and Women's Hospital, and has been a board-certified practicing internist during his career.
Tweet This: ArborMetrix names Brookings' quality healthcare expert Mark McClellan to Board | #specialtycare #acutecare @ArborMetrix
ArborMetrix, Inc., located in Ann Arbor, Michigan, provides a unique, cloud-based platform for performance measurement and clinical intelligence in acute and specialty care. Based on its industry changing econometric research, ArborMetrix solutions deliver rigorous data analysis and actionable business insights while incorporating advanced risk and reliability adjustments. With valuable insights grounded in clinical evidence, ArborMetrix clients quickly achieve quality improvements and cost savings. For more information, visit www.arbormetrix.com, email [email protected] or call 734-661-7949.
Media Contact:
Amendola Communications for ArborMetrix
Tim Boivin, 224-209-6495
[email protected]
Logo - http://photos.prnewswire.com/prnh/20140217/MM66640LOGO
SOURCE ArborMetrix
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article